Trending

TCRs

Gilead develops solid tumour cell therapy with Gadeta

Gilead develops solid tumour cell therapy with Gadeta

Gilead has option to buy biotech if things go well

X

Gilead develops solid tumour cell therapy with Gadeta

https://pharmaphorum.com/news/gilead-develops-solid-tumour-cell-therapy-with-gadeta/

Immunocore and GSK pick third cancer immunotherapy target

Immunocore and GSK pick third cancer immunotherapy target

Immunocore, one of UK biotech’s brightest hopes, has selected a third target as part of its immuno-oncology partnership

X

Immunocore and GSK pick third cancer immunotherapy target

https://pharmaphorum.com/news/immunocore-gsk-pick-third-cancer-immunotherapy-target/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com